NF-κB activation has been shown to stimulate the inflammatory response of TME and promote cancer by supporting immune modulations, tumor cell survival, and paracrine signaling of pro-inflammatory cytokines in the TME [11,24]. The gene discussed is NFKB1; the disease is cancer.